SFC Fluidics, Inc. (SFC) has partnered with two companies, Diabeloop SA and PercuSense, Inc., as part of the Industry Development and Discovery Partnership that was awarded to SFC Fluidics in 2018 by JDRF.
JDRF is sponsoring this project for the development of a single integrated pod artificial pancreas (AP) system for people with type 1 diabetes (T1D). By accelerating the development of a next-generation miniaturized and user-friendly AP system, JDRF will further its goal of reducing the daily burden for people with T1D while improving their overall health outcomes. State-of-the-art AP systems such as this are especially important for children and young adults with T1D who want to achieve better outcomes while living as normal a lifestyle as possible.
The AP system currently under development will consist of an insulin pump and continuous glucose monitor (CGM) that are housed in a single on-body pod. The pod will be controlled wirelessly via a proprietary closed-loop algorithm running on a handheld device. For the past year, SFC has focused on the optimization of its proprietary insulin pumping technology and platform. The key features of SFC’s insulin pump include best-in-class accuracy and precision at very small dose volumes, a two-valve safety system, and a dispense confirmation sensor. PercuSense will contribute its cutting edge CGM that features calibration-free glucose detection. PercuSense is dedicated to the development of a simple inserter and low-cost manufacturing. Diabeloop, a pioneer in diabetes management, will contribute a machine-learning control algorithm to automate insulin delivery.